Big-picture patterns of DNA packaging, gene activation and mutations could hold the information needed to develop a blood-based biopsy for small cell lung cancer patients, according to new work ...

In a recent study published in Cancer Cell, researchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining ...

“The microbiome is a highly complex and diverse community of microorganisms living in and on the human body,” describes Dr. Kate Markey, Assistant Professor in the Translational Science and ...

Recent studies in this field have indicated microbial cell-free DNA (mcfDNA) testing as a viable assay capable of identifying ...

This article explores how epigenetic mechanisms control gene expression, how their disruption drives cancer and how targeting ...

An Asian multi-regional registry study of rare cancers: The MASTER KEY ASIA and MASTER KEY Japan projects. Pooled accuracy of prediction of tissue-of-origin (TOO) and frequently ‘misclassified as’ ...

Please provide your email address to receive an email when new articles are posted on . Biopsies with high donor-derived cell-free DNA levels were likely to reveal antibody-mediated rejection.

Fully cell-free process aims to further democratize personalized cancer therapeutic manufacturing with shorter turnaround times and negligible bioburden and endotoxin risks. As late-stage PCT clinical ...

EINPresswire/ -- What Is The Expected Cagr For The Cell-Free DNA (cfDNA) Blood Collection Tube Market Through 2025? The market for cell-free DNA (cfDNA) blood collection tubes has displayed remarkable ...

Pediatric ENT infections are prevalent and one of the most common reasons for antibiotic prescriptions. Turnaround times of conventional culturing assays are long leading to poor clinical management ...